Daré Bioscience Statistics
Total Valuation
DARE has a market cap or net worth of $30.58 million. The enterprise value is $27.83 million.
Market Cap | 30.58M |
Enterprise Value | 27.83M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DARE has 8.42 million shares outstanding. The number of shares has increased by 17.54% in one year.
Shares Outstanding | 8.42M |
Shares Change (YoY) | +17.54% |
Shares Change (QoQ) | +14.81% |
Owned by Insiders (%) | 1.65% |
Owned by Institutions (%) | 6.77% |
Float | 8.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.86 |
Forward PS | 3.00 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 9.88 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.56
Current Ratio | 0.56 |
Quick Ratio | 0.33 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -139.90% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $108,353 |
Profits Per Employee | -$1.11M |
Employee Count | 26 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.26% in the last 52 weeks. The beta is 1.37, so DARE's price volatility has been higher than the market average.
Beta (5Y) | 1.37 |
52-Week Price Change | -60.26% |
50-Day Moving Average | 4.56 |
200-Day Moving Average | 4.63 |
Relative Strength Index (RSI) | 44.26 |
Average Volume (20 Days) | 70,417 |
Short Selling Information
The latest short interest is 58,899, so 0.70% of the outstanding shares have been sold short.
Short Interest | 58,899 |
Short Previous Month | 419,688 |
Short % of Shares Out | 0.70% |
Short % of Float | 0.71% |
Short Ratio (days to cover) | 0.93 |
Income Statement
In the last 12 months, DARE had revenue of $2.82 million and -$28.87 million in losses. Loss per share was -$3.84.
Revenue | 2.82M |
Gross Profit | 2.81M |
Operating Income | -28.58M |
Pretax Income | -28.87M |
Net Income | -28.87M |
EBITDA | -28.77M |
EBIT | -28.87M |
Loss Per Share | -$3.84 |
Balance Sheet
The company has $4.39 million in cash and $1.64 million in debt, giving a net cash position of $2.75 million or $0.33 per share.
Cash & Cash Equivalents | 4.39M |
Total Debt | 1.64M |
Net Cash | 2.75M |
Net Cash Per Share | $0.33 |
Equity (Book Value) | -11.00M |
Book Value Per Share | -1.31 |
Working Capital | -7.74M |
Cash Flow
In the last 12 months, operating cash flow was -$29.55 million and capital expenditures -$636,726, giving a free cash flow of -$30.19 million.
Operating Cash Flow | -29.55M |
Capital Expenditures | -636,726 |
Free Cash Flow | -30.19M |
FCF Per Share | -$3.60 |
Margins
Gross margin is 99.73%, with operating and profit margins of -1,014.48% and -1,024.93%.
Gross Margin | 99.73% |
Operating Margin | -1,014.48% |
Pretax Margin | -1,024.93% |
Profit Margin | -1,024.93% |
EBITDA Margin | -1,021.40% |
EBIT Margin | -1,024.93% |
FCF Margin | -1,071.59% |
Dividends & Yields
DARE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.54% |
Shareholder Yield | -17.54% |
Earnings Yield | -94.42% |
FCF Yield | -98.72% |
Analyst Forecast
The average price target for DARE is $54.00, which is 1,387.60% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $54.00 |
Price Target Difference | 1,387.60% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 163.41% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 1, 2024. It was a reverse split with a ratio of 1:12.
Last Split Date | Jul 1, 2024 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
DARE has an Altman Z-Score of -26.21. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -26.21 |
Piotroski F-Score | n/a |